Indoximod (NLG 8189)

This product is for research use only, not for human use. We do not sell to patients.

Indoximod (NLG 8189)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
2g$290Check With Us
5g$550Check With Us
10g$825Check With Us

Cat #: V0941 CAS #: 110117-83-4 Purity ≥ 98%

Description: Indoximod (NLG-8189; 1-Methyl-D-tryptophan; Indoximod; NLG8189; D1MT) is a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor with potential immunomodulating and antitumor activity.

References: Hou DY, et al. Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophancorrelates with antitumor responses. Cancer Res. 2007 Jan 15;67(2):792-801.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)218.25
Molecular FormulaC12H14N2O2
CAS No.110117-83-4
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 1 mg/mL (4.6 mM)r
Water: <1 mg/mLr
Ethanol: <1 mg/mL
SMILES CodeN[C@H](CC1=CN(C)C2=CC=CC=C12)C(O)=O
SynonymsNLG 8189; 1-Methyl-D-tryptophan; Indoximod; NLG8189; NLG-8189; D1MT;
ProtocolIn VitroThe IDO inhibitor 1-methyl-tryptophan exists in two stereoisomers with potentially different biological properties. The L isomer is the more potent inhibitor of IDO activity using the purified enzyme and in HeLa cell–based assays. However, the D isomer is significantly more effective in reversing the suppression of T cells created by IDO-expressing dendritic cells. The L isomer of 1-methyl-tryptophan functioned as a competitive inhibitor (Ki=19 μM), whereas the d isomer is much less effective. The DL mixture is intermediate, with a Ki of 35 μM.
In VivoThe D isomer is more efficacious as an anticancer agent in chemo-immunotherapy regimens using NSC-26271, NSC 125973, or LY 188011, when tested in mouse models of transplantable melanoma and transplantable and autochthonous breast cancer. The D isomer of 1-methyl-tryptophan specifically targets the IDO gene because the antitumor effect of d-1-methyl-tryptophan is completely lost in mice with a disruption of the IDO gene (IDO-knockout mice). Oral administration of dl-1-methyl-tryptophan in combination with NSC 125973 can elicit regression of autochthonous breast tumors.
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM4.5819 mL22.9095 mL45.8190 mL91.6380 mL
5mM0.9164 mL4.5819 mL9.1638 mL18.3276 mL
10mM0.4582 mL2.2910 mL4.5819 mL9.1638 mL
20mM0.2291 mL1.1455 mL2.2910 mL4.5819 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.